Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,035 | 1,602 | -2,865 | 2,718 | 7,099 |
| Depreciation Amortization | 3,485 | 2,295 | 1,141 | 4,279 | 2,855 |
| Income taxes - deferred | -1,143 | 269 | 1,892 | 1,712 | 118 |
| Accounts receivable | -3,524 | -2,887 | 3,029 | 2,052 | 14,852 |
| Other Working Capital | -15,465 | -20,113 | -12,919 | 19,571 | 2,876 |
| Other Operating Activity | 3,994 | 5,385 | -1,701 | -5,565 | -14,472 |
| Operating Cash Flow | $-11,618 | $-13,449 | $-11,423 | $24,767 | $13,328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,310 | -3,476 | -888 | -4,353 | -4,454 |
| Net Acquisitions | -525 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-3,835 | $-3,476 | $-888 | $-4,353 | $-4,454 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -2,245 | -2,812 | -14,046 | 5,781 | 1,507 |
| Debt Issued | 2,000 | 3,305 | N/A | N/A | 1,517 |
| Debt Repayment | -5,072 | -2,190 | -1,100 | -2,343 | -1,650 |
| Common Stock Issued | 488 | 84 | 39 | 916 | 273 |
| Other Financing Activity | -2,000 | -2,000 | 10,843 | -273 | -1,769 |
| Financing Cash Flow | $-6,829 | $-3,613 | $-4,264 | $4,081 | $-122 |
| Exchange Rate Effect | -550 | -739 | -365 | 4,006 | 1,277 |
| Beginning Cash Position | 43,377 | 43,377 | 43,377 | 14,876 | 14,876 |
| End Cash Position | 20,545 | 22,100 | 26,437 | 43,377 | 24,905 |
| Net Cash Flow | $-22,832 | $-21,277 | $-16,940 | $28,501 | $10,029 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,618 | -13,449 | -11,423 | 24,767 | 13,328 |
| Capital Expenditure | -3,310 | -3,476 | -888 | -4,373 | -4,454 |
| Free Cash Flow | -14,928 | -16,925 | -12,311 | 20,394 | 8,874 |